Table 1 Characteristics of study cohort
Characteristic | N of patients | GPER-1 | p-value | |
|---|---|---|---|---|
Negative | Positive | |||
N (%) | N (%) | |||
Total | 124 | 21 (16.9) | 103 (83.1) | |
Age, years (range) | 124 | 65 (30–84) | 61 (20–85) | 0.136 |
Menopausal status | ||||
premenopausal | 16 | 1 (6.2) | 15 (93.8) | |
postmenopausal | 108 | 20 (18.5) | 88 (81.5) | 0.304 |
FIGO Stage | ||||
1 | 25 | 0 (0) | 25 (100) | |
2 | 21 | 6 (28.6) | 15 (71.4) | |
3 | 76 | 14 (18.4) | 62 (81.6) | |
4 | 2 | 1 (50.0) | 1 (50) | 0.032 |
Lymph node status | ||||
negative | 31 | 5 (16.1) | 26 (83.9) | |
positive | 18 | 3 (16.7) | 15 (83.3) | 1.000 |
Histological grading | ||||
1 | 18 | 0 (0) | 18 (100) | |
2 | 38 | 7 (18.4) | 31 (81.6) | |
3 | 68 | 14 (20.6) | 54 (79.4) | 0.112 |
Histology | ||||
serous | 81 | 13 (16.0) | 68 (84.0) | |
mucinous | 16 | 3 (18.8) | 13 (81.2) | |
endometrioid | 13 | 2 (15.4) | 11 (84.6) | |
clear cell | 8 | 0 (0) | 8 (100) | |
other | 6 | 3 (50) | 3 (50) | 0.171 |
Recurrence (in 24 months) | ||||
no | 57 | 4 (7.0) | 53 (93.0) | |
yes | 67 | 17 (25.4) | 50 (74.6) | 0.008 |